Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2025-04-30 00:00:00 ET · period of report 2025-04-28 · accession 0001104659-25-042608 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-30 | 2025-04-28 | PTGX | SELICK HAROLD E | Dir | M - OptEx | $1.16 | +10.7K | 43.9K | +32% | +$12.4K |
| D | 2025-04-30 | 2025-04-28 | PTGX | SELICK HAROLD E | Dir | M - OptEx | $0.00 | -10.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-28 | M | A | 10,725 | $1.16 | 43,851 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2025-04-28 | M | D | 10,725 | $0.00 | 0 | D | $1.16 · — to 2025-10-28 | 10,725 Common Stock | (F1) These stock options are fully vested. |